TP53 and lung carcinoma: In this study, we used the novel viral B2 protein to induce different cell death pathways in A549 lung cancer cells, which express P53 (P53+/+), and H1299 lung cancer cells, which do not express P53 (P53—/—), and also examined relationship of activation of these different pathways with suppression of autophagy.